
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with In-office from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/inoffice/topic/9241/</link>
        <description>Articles tagged with In-office from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Intuniv patient kit draws DDMAC untitled letter</title>
          <description>Patient materials for Shire&apos;s ADHD drug Intuniv presented unsubstantiated effectiveness and superiority claims and downplayed important risk info, said the FDA&apos;s Division of Drug Marketing, Advertising and Communication.</description>
          <link>http://www.mmm-online.com/intuniv-patient-kit-draws-ddmac-untitled-letter/article/173674/</link>
          <pubDate>Wed, 30 Jun 2010 23:12:53 GMT</pubDate>
          <itunes:summary>Patient materials for Shire&apos;s ADHD drug Intuniv presented unsubstantiated effectiveness and superiority claims and downplayed important risk info, said the FDA&apos;s Division of Drug Marketing, Advertising and Communication.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  